Abstract:Abstract Treg cells play an important role in maintaining immunologic homeostasis. Abnormal Treg were found in some autoimmune diseases. Infusion of natural Treg (nTreg) prevents some autoimmune disease but usually fails to treat established diseases. Several studies demonstrated nTreg could be transdifferentiated into Th17 cells and lost its function under inflammatory condition. Given IL-6 is an important inflammatory cytokine and it binds to its receptor (CD126) to exert functional role, whereas nTreg express CD126, we hypothesize that CD126− Foxp3+ cell subsets could be more stable and functional in the inflammatory condition. CD126+ and CD126− nTreg were sorted from collagen-induced arthritis (CIA) and then were analyzed for transcript difference via RNA-sequence. They were cultured in the presence of IL-6 to determine the stability and function following a colitis model in vivo. Compared to normal mice, the proportion of CD126+ nTreg in CIA was significantly higher. CD126− nTreg express higher immunosuppressive molecules and present stronger function than CD126+ nTreg in both normal condition and presence of IL-6. Moreover, CD126− nTreg was stable while CD126+ nTreg lost Foxp3 expression and trans-differentiated into Th17 in the presence of IL-6. In addition, CD126− nTreg exhibited reduced Hif-1a and glucose transporter 1(Slc2a1) expression, which are two key regulators of glycolytic metabolism and play an important role in the balance of Th17 and Treg. Finally, CD126− Treg more potent treat colitis compared to control. We show CD126− nTreg present stronger function and stability under inflammatory conditions Our results suggest that manipulation of CD126− nTreg might be a novel strategy for the treatment of autoimmune diseases.

CD226 maintains regulatory T cell phenotype stability and metabolism by the mTOR/Myc pathway under inflammatory conditions

Ubc13 maintains the suppressive function of regulatory T cells and prevents their conversion into effector-like T cells

CD226 Attenuates Treg Proliferation via Akt and Erk Signaling in an EAE Model

CD226 deficiency attenuates the homeostasis and suppressive capacity of Tr1 cells

Tuberous Sclerosis 1 (Tsc1)-Dependent Metabolic Checkpoint Controls Development of Dendritic Cells

Metabolic Control of Regulatory T Cell Stability and Function by TRAF3IP3 at the Lysosome.

CD226 knockout alleviates high-fat diet induced obesity by suppressing proinflammatory macrophage phenotype

Disruption of Tsc1/2 Signaling Complex Reveals A Checkpoint Governing Thymic Cd4(+)Cd25(+)Foxp3(+), Regulatory T-Cell Development in Mice

TSC 1 Regulates the Balance Between Effector and Regulatory T Cells

TSC1 controls macrophage polarization to prevent inflammatory disease

AMP-activated protein kinase alpha1 promotes tumor development via FOXP3 elevation in tumor-infiltrating Treg cells

CD126 Negative Regulatory Cells Represents a Superior Treg Subset in Treating Autoimmune Diseases

TSC2 S1365A mutation potently regulates CD8+ T cell function and differentiation and improves adoptive cellular cancer therapy

CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells

TGFβ limits Myc-dependent TCR-induced metabolic reprogramming in CD8+ T cells

Tumor Suppressor TSC1 is Critical for T-cell Anergy

Metabolic Regulation of T Cell Development by Sin1–mTORC2 is Mediated by Pyruvate Kinase M2

mTORC1 Signaling Regulates Proinflammatory Macrophage Function and Metabolism

Excess generation and activation of naturally arising memory-phenotype CD4+ T lymphocytes are inhibited by regulatory T cells in steady state

Inhibitory co-receptor Lag3 supports Foxp3+ regulatory T cell function by restraining Myc-dependent metabolic programming

CXXC-finger protein 1 associates with FOXP3 to stabilize homeostasis and suppressive functions of regulatory T cells